This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A PRELIMINARY REPORT

ALICE G. HILDEBRAND, M.D.; EDWARD H. RYNEARSON, M.D.

Arch Intern Med. 1943;72(1):37-45.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

All physicians who treat diabetes mellitus have long been interested in the perfecting of some type of delayed action insulin which would adequately control the level of sugar in the blood when injected once in each twenty-four hours. It was hoped that protamine zinc insulin, introduced in 1936 by Hagedorn and his associates¹ would be the answer to the problem of a depot of insulin. However, further experience with this type of insulin revealed that a single injection in each twenty-four hours was incapable of giving satisfactory control of the blood sugar in many cases of severe diabetes. In such cases it was often not possible to give sufficient protamine zinc insulin to control postprandial hyperglycemia during the day without producing nocturnal insulin reactions. Consequently, most authors have agreed that for satisfactory control of severe diabetes mellitus protamine zinc insulin must be supplemented by unmodified insulin.² In this . . . [Full Text PDF of this Article]

Author Affiliations
ROCHESTER, MINN.

From the Division of Medicine, Mayo Clinic.

Footnotes
Fellow in Medicine, Mayo Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?